At a glance
ClinicalIndex Comparison RecordN/ACompleted· 25 enrolled
Drug / intervention
tACS (alpha) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Targeting Auditory Hallucinations With Alternating Current Stimulation
In Brief
A clinical study evaluating tACS (alpha) and tDCS for Schizophrenia and Schizoaffective Disorder. Completed, enrolled 25 participants across 1 site.
Detailed Summary
Investigating the effects of non-invasive transcranial current stimulation as a treatment for auditory hallucinations in patients with schizophrenia.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSchizophrenia, Schizoaffective Disorder
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedFeb 2015
Enrollment StartMay 2015
Primary CompletionFeb 2017
TodayJul 2026
First PostedFeb 10, 2015
Enrollment StartMay 1, 2015
Primary CompletionFeb 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 11.4 years ago
Interventions
tACS (alpha)device
tDCSdevice